Clinical outcome of three fractionation schedules of preoperative radiotherapy for rectal cancer

被引:0
|
作者
Wzietek, Iwona [1 ,2 ]
Wydmanski, Jerzy [1 ,2 ]
Suwinski, Rafal [1 ,2 ]
机构
[1] Maria Sklodowska Curie Mem Canc Ctr, Dept Radiat Oncol, Wybrzeze AK 15, PL-44101 Gliwice, Poland
[2] Inst Oncol, Gliwice Branch, Gliwice, Poland
关键词
preoperative radiotherapy; rectal cancer; fractionation;
D O I
10.1016/S1507-1367(10)60004-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
AIM: To evaluate the effectiveness and normal tissue reactions of three fractionation schedules of preoperative radiotherapy for locally advanced rectal cancer. MATERIALS AND METHODS: Between 1996 and 2002, 168 patients with locally advanced rectal cancer were treated as follows: 53 patients received 25 Gy in 5 Gy per fraction (group A), 45 received 30 Gy in 3.0 Gy per fraction (group B), and 70 were treated with accelerated hyperfractionation: 42 Gy, 1.5 Gy per fraction, given twice a day with an inter-fraction interval of 6 hours (group C). The clinical characteristics of the groups were comparable. The patients did not receive concurrent chemotherapy. A Cox proportional hazard regression model was used to analyze the factors which may influence loco-regional tumour control (LRC) and overall survival (OS). RESULTS: The following variables significantly influenced LRC: fractionation scheme (5-year LRC 80%, 69%, and 90% in groups A, B, C respectively, p=0.016), haemoglobin concentration before radiotherapy (p=0.012) and postoperative chemotherapy (p=0.01). Age, sex, stage of disease, location of tumour (distance of the tumour from the anal verge) and performance status did not appear significant for LRC. The overall 5-year OS was 64%, 59% and 74% in groups A, B, C respectively (p=0.056). The OS was significantly influenced by postoperative pathological stage (p=0.006), tumour location (p=0.015) and postoperative chemotherapy (p=0.047). The most frequent acute radiation reaction was mild/severe diarrhoea, which appeared in 5%, 21.6% and 65.5% of the patients from groups A-C respectively. The median wound healing time in those who underwent abdomino-perineal resections was 6, 6 and 4 weeks. Other reactions appeared less relevant. There was no significant difference in the incidence of late effects among the three treatment groups. CONCLUSION: While due to the non-randomized character of the study the conclusions should be regarded as hypothesis-generating only, the analysis has shown an acceptable local effectiveness and tolerance of schedules A and C, and disappointing effectiveness of schedule B. The present study thus supports the data which suggest that the clinical effect of preoperative radiotherapy for rectal cancer is influenced not only by total radiation dose but also by overall radiation treatment time and dose per fraction.
引用
收藏
页码:135 / 143
页数:9
相关论文
共 50 条
  • [41] Decision consultations on preoperative radiotherapy for rectal cancer: large variation in benefits and harms that are addressed
    M Kunneman
    C A M Marijnen
    T Rozema
    H M Ceha
    D A R H Grootenboers
    K J Neelis
    A M Stiggelbout
    A H Pieterse
    British Journal of Cancer, 2015, 112 : 39 - 43
  • [42] WRAP53 is an independent prognostic factor in rectal cancer- a study of Swedish clinical trial of preoperative radiotherapy in rectal cancer patients
    Zhang, Hong
    Wang, Da-Wei
    Adell, Gunnar
    Sun, Xiao-Feng
    BMC CANCER, 2012, 12
  • [43] The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer: a practice guideline
    Alvaro Figueredo
    Lisa Zuraw
    Rebecca KS Wong
    Olusegun Agboola
    R Bryan Rumble
    Ved Tandan
    BMC Medicine, 1
  • [44] hPEBP4 as a predictive marker for the pathological response of rectal cancer to preoperative radiotherapy
    Qiu, Jianming
    Yang, Guangen
    Shen, Zhong
    Xie, Ya
    Wang, Lewei
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2013, 28 (02) : 241 - 246
  • [45] Cost-effectiveness of preoperative radiotherapy in rectal cancer:: Results from the Swedish Rectal Cancer Trial
    Dahlberg, M
    Stenborg, A
    Påhlman, L
    Glimelius, B
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (03): : 654 - 660
  • [46] WRAP53 is an independent prognostic factor in rectal cancer- a study of Swedish clinical trial of preoperative radiotherapy in rectal cancer patients
    Hong Zhang
    Da-Wei Wang
    Gunnar Adell
    Xiao-Feng Sun
    BMC Cancer, 12
  • [47] Down-staging after two different preoperative chemoradiation schedules in rectal cancer
    Grillo-Ruggieri, F
    Mantello, G
    Cardinali, M
    Fabbietti, L
    Fenu, F
    Montisci, M
    Bracci, R
    Delprete, S
    Guerrieri, M
    Marmorale, C
    TUMORI, 2003, 89 (02) : 164 - 167
  • [48] Outcome of patients with clinical stage II or III rectal cancer treated without adjuvant radiotherapy
    Fujita, Shin
    Yamamoto, Seiichiro
    Akasu, Takayuki
    Moriya, Yoshihiro
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2008, 23 (11) : 1073 - 1079
  • [49] Gender differences in stage at diagnosis and preoperative radiotherapy in patients with rectal cancer
    Cristina Sarasqueta
    Mª Victoria Zunzunegui
    José María Enríquez Navascues
    Arrate Querejeta
    Carlos Placer
    Amaia Perales
    Nerea Gonzalez
    Urko Aguirre
    Marisa Baré
    Antonio Escobar
    José María Quintana
    BMC Cancer, 20
  • [50] Prognostic significance of adverse events associated with preoperative radiotherapy for rectal cancer
    Soichiro Ishihara
    Toshiaki Watanabe
    Takuya Akahane
    Ryu Shimada
    Atsushi Horiuchi
    Hajima Shibuya
    Tamuro Hayama
    Hideki Yamada
    Keijiro Nozawa
    Hiroshi Igaki
    Keiji Matsuda
    International Journal of Colorectal Disease, 2011, 26 : 911 - 917